Shares of Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) person earned an mean proposal of "Moderate Buy" from nan thirteen analysts that are covering nan stock, Marketbeat reports. One finance expert has rated nan banal pinch a clasp proposal and 12 person issued a…
This communicative appeared connected marketbeat.com, 2024-10-26 09:26:04.